Results 161 to 170 of about 898,653 (339)
Percutaneous femoro‐femoral V‐A ECMO cannulation was associated with more than a two‐fold lower risk of site bleeding and nearly a six‐fold lower risk of infection compared with surgical cut‐down, with no difference in limb ischemia. Absence of distal perfusion catheterization and larger arterial cannula size were additional modifiable ischemia risk ...
Axel Dimberg +3 more
wiley +1 more source
Unilateral Pulmonary Edema: A Rare Initial Presentation of Cardiogenic Shock due to Acute Myocardial Infarction [PDF]
Jeong‐Hun Shin +10 more
openalex +1 more source
How does protocolization improve outcomes in cardiogenic shock due to end-stage heart failure?
Hoong Sern Lim
openalex +2 more sources
Low ICU Admission and Excellent Outcomes in MIS‐C: A Swedish Study From an Open Society
ABSTRACT Aim During the COVID‐19 pandemic, Sweden chose a more open public health approach. A general concern was that this approach would affect the population negatively. We describe the Swedish national MIS‐C cohort and risk factors for severe disease defined as admission to the intensive care unit and cardiogenic shock.
Petra Król +13 more
wiley +1 more source
Antimicrobial prescribing guidelines for horses in Australia
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt +18 more
wiley +1 more source
Extracorporeal Cardiopulmonary Resuscitation [PDF]
Extracorporeal cardiopulmonary resuscitation (ECPR) is a method of resuscitation in which venoarterial (VA) extracorporeal membrane oxygenation(ECMO) is initiated during refractory cardiac arrest. ECPR promises to enhance outcomes after cardiac arrest by
Carr, Emily
core +1 more source
Prognostic value of red blood cell distribution width-to-albumin ratio in patients with Cardiogenic shock - A cohort study [PDF]
Yangjing Xue +3 more
openalex +1 more source
Levosmindan: A new step up in Management in Neonatal Cardiogenic shock [PDF]
H A Awad +7 more
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source

